Chloride ion
- Generic Name
- Chloride ion
- Drug Type
- Small Molecule
- Chemical Formula
- Cl
- CAS Number
- 16887-00-6
- Unique Ingredient Identifier
- Q32ZN48698
Pain Management After Adductor Canal Block for Total Knee Arthroplasty
- Conditions
- Knee Pain ChronicKnee OsteoarthritisKnee ArthritisKnee Arthropathy
- Interventions
- First Posted Date
- 2023-10-17
- Last Posted Date
- 2023-10-17
- Lead Sponsor
- Poznan University of Medical Sciences
- Target Recruit Count
- 361
- Registration Number
- NCT06086483
- Locations
- 🇵🇱
Poznan University of Medical Sciences, Poznan, Poznań, Poland
Clinical Analysis of Vitamin B6 in Sepsis
- Conditions
- Vitamin B6Oxidative Stress ResponseSepsisKidney InjuryInflammatory Response
- Interventions
- First Posted Date
- 2023-08-23
- Last Posted Date
- 2023-08-23
- Lead Sponsor
- The First People's Hospital of Huzhou
- Target Recruit Count
- 128
- Registration Number
- NCT06008223
- Locations
- 🇨🇳
Wen-Ming Feng, Huzhou, Zhejiang, China
A Phase 2b Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat.
- Conditions
- Subcutaneous Fat
- Interventions
- First Posted Date
- 2023-08-22
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Caliway Biopharmaceuticals Co., Ltd.
- Target Recruit Count
- 173
- Registration Number
- NCT06005441
- Locations
- 🇺🇸
Investigational Site 1, Omaha, Nebraska, United States
A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During Surgery in People With or Without Kidney Disease
- Conditions
- Intraoperative Ureter VisualizationAbdominolpelvic Surgery
- Interventions
- First Posted Date
- 2023-08-21
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- Astellas Pharma Global Development, Inc.
- Target Recruit Count
- 94
- Registration Number
- NCT05999747
- Locations
- 🇺🇸
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
🇺🇸University of South Florida, Tampa, Florida, United States
🇺🇸Cleveland Clinic Florida, Weston, Florida, United States
Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial Cystitis
- Conditions
- Interstitial Cystitis
- Interventions
- First Posted Date
- 2023-06-22
- Last Posted Date
- 2023-09-15
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 129
- Registration Number
- NCT05912946
Clinical Trail of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) in Participants Aged 18 Years and Older
- Conditions
- SARS-CoV-2
- Interventions
- Biological: SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021)
- First Posted Date
- 2023-04-13
- Last Posted Date
- 2023-04-19
- Lead Sponsor
- AIM Vaccine Co., Ltd.
- Target Recruit Count
- 9800
- Registration Number
- NCT05812014
- Locations
- 🇵🇰
Sindh Infectious Diseases Hospital & Research Center Dow University of Health Sciences, Islamabad, Pakistan
0.9% Saline Versus Balanced Solutions in Severe Diabetic Ketoacidosis
- Conditions
- AcetonuriaAcetonemiaKetoacidemiaMetabolic Ketoacidosis
- Interventions
- Drug: Ringer lactate (RL)
- First Posted Date
- 2023-04-12
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Tunis University
- Target Recruit Count
- 92
- Registration Number
- NCT05808972
- Locations
- 🇹🇳
Ahlem Trifi, Tunis, Tunisia
A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During Surgery
- Conditions
- Abdominolpelvic SurgeryIntraoperative Ureter Visualization
- Interventions
- First Posted Date
- 2023-03-03
- Last Posted Date
- 2025-01-30
- Lead Sponsor
- Astellas Pharma Global Development, Inc.
- Target Recruit Count
- 107
- Registration Number
- NCT05754333
- Locations
- 🇺🇸
AdventHealth Orlando, Orlando, Florida, United States
🇺🇸Advent Health Tampa, Tampa, Florida, United States
🇺🇸Cleveland Clinic Florida, Weston, Florida, United States
Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis
- Conditions
- Diabetic Ketoacidosis
- Interventions
- First Posted Date
- 2023-03-02
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 680
- Registration Number
- NCT05752279
- Locations
- 🇦🇺
Royal North Shore Hospital, St Leonards, New South Wales, Australia
🇦🇺Redcliffe Hospital, Redcliffe, Queensland, Australia
A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Patients With Pulmonary Hypertension After Cardiopulmonary Bypass Surgery
- Conditions
- Pulmonary Hypertension
- Interventions
- First Posted Date
- 2023-01-26
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- Attgeno AB
- Target Recruit Count
- 12
- Registration Number
- NCT05699486
- Locations
- 🇸🇪
Sahlgrenska University Hospital, Anaesthesiology and Intensive Care, Gothenburg, Sweden
🇸🇪Örebro University Hospital, Vascular and Thoracic Department (Kärl-Thoraxkliniken), Örebro, Sweden
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.